<DOC>
	<DOCNO>NCT02913326</DOCNO>
	<brief_summary>This multi-center , prospective , international , randomize ( 1:1 ) , open-label study two parallel group . This phase III study plan investigate efficacy safety dabigatran etexilate versus dose-adjusted warfarin net clinical benefit endpoint major bleeding ( ISTH criterion ) new venous thrombotic event ( VTE ) ( primary endpoint ) blind endpoint adjudication .</brief_summary>
	<brief_title>A Clinical Trial Comparing Efficacy Safety Dabigatran Etexilate With Warfarin Patients With Cerebral Venous Dural Sinus Thrombosis ( RE-SPECT CVT )</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Sinus Thrombosis , Intracranial</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criterion : Written inform consent accordance International Conference Harmonization ( ICH ) Good Clinical Practice ( GCP ) guideline local legislation and/or regulation Confirmed diagnosis Cerebral Venous dural sinus thrombosis ( CVT ) , without intracranial haemorrhage Completion anticoagulation therapy 515 day administer randomisation ; anticoagulation must include fulldose low molecular weight heparin unfractionated heparin Eligibility treatment oral anticoagulant Further inclusion criterion apply Exclusion criterion : Cerebral Venous dural sinus thrombosis ( CVT ) associate central nervous system infection due head trauma Planned surgical treatment CVT Conditions associate increase risk bleed History symptomatic nontraumatic intracranial haemorrhage risk recurrence accord Investigator judgment Treatment antithrombotic regimen indication CVT require continuation treatment original diagnosis without change regimen Severe renal impairment Active liver disease Preganancy , nurse plan become pregnant trial Further exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>